镍钛记忆合金环抱器治疗锁骨骨折利弊

锁骨骨折是临床较常见的骨折之一.近几年应用镍钛记忆合金环抱器治疗锁骨骨折的报道较多,但报道其优点较多,很少谈其缺点及不足.2005年1月～2007年1月,我科收治24例锁骨骨折患者,采用镍钛记忆合金环抱器治疗,笔者对其利弊进行分析如下.     

肱骨近端记忆接骨器的设计与临床应用

目的 探索肱骨头解剖颈至外科颈及肱骨近端干段骨折、骨不连的内固定新技术。方法 根据生物记忆材料镍钛合金性能与肱骨近端解剖生理特征，研制肱骨近端记忆接骨器（proximal humerus memory connector，PHMC），并临床治疗肱骨近端粉碎性骨折、畸形愈合、骨不连共22例。患者平均年龄41．7岁，平均随访18．5个月。结果 骨折骨性愈合时间平均3．6个月；骨不连骨性愈合时间平均4．5个月。骨愈合形式均呈骨板样骨替代，未见无序骨痂出现。PHMC术后弃用外固定，创伤反应期（7～12d）后，进行主动渐进性功能锻炼。肩关节功能按Michael Reese评分，平均88．5分。结论 PHMC能有效治疗肱骨解剖颈始至肱骨近端的各类型骨折与骨不连，亦为减少该部的假体关节置换探索出了新路。     

The Effect of Desensitization Protocols on Human Splenic B-Cell Populations In Vivo

Rituximab, intravenous immunoglobulin (IVIG) and rabbit antithymocyte globulin (rATG) all have been suggested to have an effect on antibody producing cells, however, supporting data are lacking. To assess the impact of these agents on splenic B‐cell populations in vivo, we retrospectively examined 25 spleens removed from patients treated with these agents as part of desensitization protocols in either ABO incompatible or positive crossmatch living donor kidney transplantation. These were compared to control (CTL) spleens removed for trauma. CTLs and spleens removed at transplant after multiple pretransplant plasmaphereses (PP) plus low‐dose IVIG showed similar large numbers of naïve B cells (CD20⁺ and CD79⁺), plasma cells (CD138⁺) and memory B cells (CD27⁺ cells). Adding rituximab to this PP/IVIG regimen reduced the number naïve B cells, but had no effect on memory or plasma cells. Combination treatment (PP/IVIG, rituximab and rATG) showed a trend toward the reduction of CD27⁺ cells, but again plasma cells were unchanged. We conclude that none of these protocols reduces splenic plasma cells in vivo. PP/low‐dose IVIG does not alter splenic B cells, but the addition of rituximab decreases mature B cells. Memory B cells may be affected by combination therapy including rATG and requires further study.     

异丙酚对记忆功能的影响及相关脑机制

异丙酚作为一种短效、快速的静脉全麻药目前已在临床上广泛使用。同时，作为一种镇静-催眠药，它会影响人的注意力，对记忆造成短期或长期的干扰。探讨异丙酚对记忆的影响，不仅有助于更好地了解其在临床使用的安全性，确定其是否会对患者记忆功能造成不可逆的损伤，还将有助于进一步揭示全身麻醉的机制。     

天鹅型形状记忆合金接骨器对实验性骨折愈合中皮质骨胶原构筑与力学性能的影响

目的探讨天鹅型形状记忆合金接骨器(SMC)对实验性骨折愈合中皮质骨胶原构筑和力学性能的影响。方法45只新西兰大白兔双侧肱骨干截骨后,随机选取一侧用SMC固定,另一侧用4孔动力加压接骨板(DCP)固定;分别于术后2、4、8、16、32周各处死9只动物取材,4只用于扫描电镜观察固定段皮质骨胶原构筑的变化,5只用于骨干扭转生物力学性能的测定。结果SMC组在整个固定过程中,皮质骨结构与正常对照组相比无明显变化。而DCP组术后4周,胶原排列出现稀疏,局部有小吸收陷窝形成;术后8周时,胶原排列紊乱,且有多个吸收腔形成;术后16周时,胶原纤维出现中断;术后32周,骨质疏松化更加明显。术后2周时,两组肱骨骨断端尚未形成骨性连接,不能测得力学数据。术后4～32周,SMC组骨折愈合部位的扭转刚度明显优于DCP组,差异有统计学意义(F= 5．468,P＜0．05)。术后16周,SMC组骨折愈合部位的力学性能即接近正常,而DCP组术后16周扭转刚度即不再增加。结论SMC具有材料特性和几何构型上的优势,对骨干不产生应力遮挡效应,而且能有效防止骨质疏松的发生,使骨的力学性能尽早恢复。     

含钛合金及Ni-Cr合金与瓷粉结合强度的实验研究

目的:研究含钛合金(4%～6%)[熔附HeraCeramJC瓷粉(A1组)和Vita瓷粉(A2组)]、HeraCeram公司的Ni-Cr合金[熔附HeraCeramJC瓷粉(B1组)和Vita瓷粉(B2组)]及西北有色金属厂的Ni-Cr合金[熔附HeraCeramJC瓷粉(C1组)和Vita瓷粉(C2组)]的金-瓷结合强度,为临床工作提供参考。方法:运用三点弯曲法对各组的金-瓷结合强度进行测试,并对金-瓷结合界面进行电镜观察分析。结果:电镜显示各组瓷粉均与金属基体结合紧密,无明显气泡、中间层等缺陷。结合强度:A1组:(41.08±2.98)MPa,B1组:(46.05±3.16)MPa,C1组:(44.04±3.69)Mpa;A2组:(42.29±3.38)MPa,B2组:(42.05±3.26)MPa,C2组:(47.47±2.92)MPa。①HeraCeramJC瓷粉与3种合金结合的结合强度比较:B1>A1(P<0.05);B1>C1、C1>A1(P>0.05)。②Vita瓷粉与3种合金结合的结合强度比较:C2>A2、C2>B2(P<0.05);A2>B2(P>0.05)。结论:本实验表明临床常用的3种非贵合金与瓷粉的金-瓷结合强度均大于ISO所要求的基本值25MPa,但各组间还存在一定差异,为临床工作中根据患者的具体情况选择合适的烤瓷修复基底材料和瓷粉提供实验依据。     

钛合金板置入在颅骨缺损修复中的应用

目的:探讨钛合金板置入在颅骨缺损修复中的应用。方法:对12例颅骨缺损的患者先进行三维CT检查,设计个性化的钛合金板置入以修复颅骨缺损。结果:本组患者均愈合良好,无感染、钛板外露及头皮血运障碍,避免了再次手术。结论:应用钛合金板修复颅骨缺损,具有良好的生物学力度,抗击性强,并发症少,生物相容性好等优点,可获得较好的治疗效果。     

镍钛形状记忆合金内固定器治疗四肢骨折失败原因与对策分析

[目的]探讨镍钛形状记忆合金内固定器治疗四肢骨折的失败原因与对策.[方法]回顾分析镍钛形状记忆合金内固定器治疗四肢骨折259例中,8例术后出现内固定器松动、松脱、断裂的原因及处理方法.[结果]259例骨折患者中内固定失败8例,发生率3.1%;其中尺骨骨折1例、股骨骨折2例术后内固定器断裂,二次手术达骨性愈合;锁骨骨折2例,肱骨及股骨骨折各1例术后出现内固定器松动翘起,骨折畸形愈合;1例髌骨骨折骨折愈合后髌骨爪松脱.[结论]镍钛形状记忆合金内固定器治疗四肢骨折只有严格掌握手术指征,根据不同部位选择最佳的型号及长度,术中规范操作,术后进行安全的康复锻炼,才能避免内固定失败的发生.     

Maturation of executive function in autism.

BACKGROUND: Executive dysfunction has been reported at different ages in autism. It is not clear however, when this impairment emerges or how its expression is affected by development. METHODS: 61 non-mentally retarded autism participants (AUT) and 61 age, gender, and IQ matched typically developing participants (CON) were assessed with two oculomotor executive function tasks, the oculomotor delayed response task (ODR) and the antisaccade task (AS), as well as a visually-guided saccade sensorimotor task (VGS). RESULTS: The AUT group demonstrated impairments in response inhibition and spatial working memory at all ages tested. Developmental improvements in speed of sensorimotor processing and voluntary response inhibition were similar in both groups indicating sparing of some attentional control of behavior. Developmental progression in the speed of initiating a cognitive plan and maintaining information on line over time, however, was impaired in the AUT group indicating abnormal development of working memory. CONCLUSIONS: These results indicate that while executive dysfunction is present throughout development, there is evidence for both typical and atypical developmental progression of executive functions in autism. The plasticity suggested by the developmental improvements may have implications regarding appropriate developmental epochs and types of interventions aimed at enhancing cognitive capacities in individuals with autism.     

义齿用Ti-6Al-7Nb合金铸件挠度的研究

目的：通过对相同长度、宽度、不同厚度的Ti-6Al-7Nb合金铸件挠度的测量,观察铸件厚度与挠度的关系,为确定Ti-6Al-7Nb合金铸造义齿基托的适合厚度提供实验依据。方法：参照ISO关于义齿基托材料挠度的标准,测量不同厚度Ti-6Al-7Nb合金铸件的挠度,并与纯钛、Ti-6Al-4V合金及Co-Cr合金对比。结果：Ti-6Al-7Nb合金、纯钛及Ti-6Al-4V合金铸件的厚度在0.65mm时可以达到义齿基托挠度的标准;Co-Cr合金在0.57mm时可达到标准要求。结论：在临床制作Ti-6Al-7Nb合金义齿基托时,厚度应不低于0.65mm。